#United States #New York #Levi & Korsinsky #PMI #Picard Medical

Investors Encouraged to Join Class Action Against Picard Medical, Inc.

In a recent announcement, Levi & Korsinsky, LLP has alerted shareholders of Picard Medical, Inc. (NYSE: PMI) regarding an ongoing class action lawsuit. This legal action is aimed at compensating investors who suffered financial losses due to alleged securities fraud activities involving the Company.

Understanding the Class Action

This class action targets individuals who purchased shares of Picard Medical between September 2, 2025, and October 31, 2025. The underlying issue arises from to claims of misleading practices that inflated stock prices while concealing significant operational issues.

The filed complaint contends that the Company was implicated in a fraudulent stock promotion scheme, where misinformation was propagated through social media, misleading investors about the company's true financial state. Several troubling allegations have emerged, asserting that insiders may have engaged in stock dumping through offshore accounts while hiding crucial operational risks from investors.

Key points raised in the complaint include:
1. Misleading public statements regarding the integrity and safety of the Company's operations.
2. Concealment of artificially inflated trading activities that created an unwarranted surge in stock prices.
3. Lack of transparency surrounding rumors and misinformation that could significantly influence investor decisions.

The Implications for Investors
Those who have experienced losses from investing in Picard Medical are given the opportunity to fight back. They are urged to contact Levi & Korsinsky for further information on joining the class action before the deadline of April 3, 2026. Early participation may entitle them to potential compensation, regardless of their involvement in leading the case.

How to Join the Class Action

Shareholders looking to take part can reach out via the attorney, Joseph E. Levi, at (212) 363-7500 or through email at [email protected]. Additionally, interested investors can fill out a registration form available through the law firm’s website.

The legal representatives emphasize that participation in the class action comes at no cost to the shareholders. Investors can pursue compensation without any obligations or out-of-pocket costs, ensuring that everyone has the chance to recover some of their losses.

Why Choose Levi & Korsinsky?

Levi & Korsinsky, known for its robust track record in securities litigation, has secured hundreds of millions for shareholders in similar cases over the past two decades. They consistently rank among the top firms handling securities class actions in the United States, managing complex legal battles with a seasoned team dedicated to advocating for investor rights.

Contact Information
For more details, or to inquire further about this lawsuit, investors can reach out to:
Levi & Korsinsky, LLP
33 Whitehall Street, 27th Floor
New York, NY 10004
Email: [email protected]
Phone: (212) 363-7500

In light of these recent developments, Picard Medical investors should be proactive in seeking information and potentially joining the class action lawsuit to navigate their recovery options. As this case unfolds, more details will emerge, providing clarity on the next steps for affected parties.